Arkolith/Insider Trading/CRDF/Form 4

Levine James E.

Chief Financial OfficerCardiff Oncology, Inc. (CRDF) · full profile →Form 4 · filed Dec 18, 2024
Net Buying
Open-Market Buys
$37K
Open-Market Sells
$0
Net Open-Market Flow
$37K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 18, 2024Buy(P)2K$5.00$12K68K
Dec 17, 2024Buy(P)3K$5.42$15K65K
Dec 16, 2024Buy(P)3K$3.83$10K63K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-137938) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML